Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s42399-020-00704-3 http://scihub22266oqcxt.onion/10.1007/s42399-020-00704-3 33458569!7801564!33458569     free     free     free       SN+Compr+Clin+Med 2021 ; 3 (1): 11-15 Nephropedia Template TP {{tp|p=33458569|t=2021. Re-reading ACT, BCG, and Low COVID-19 in Africa |pdf=|usr=}}{{33458569}} gab.com Text Re-reading ACT, BCG, and Low COVID-19 in Africa JO: SN Compr Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=33458569 #FOAvip October 11, 2020, marks the seventh month since the World Health Organization (WHO) officially declared COVID-19 a pandemic. Unlike other coronavirus diseases, there is a geographically disproportionate distribution of the incidence of COVID-19 cases around the world. We observed a significantly high COVID-19 cases and deaths in countries and territories with no or very small number of malaria cases or no or low national TB cases in 2018. We speculate that the high incidence of COVID-19 cases and deaths in countries less affected by malaria is partly due to overexposure to malaria which led to the regular use of the artemisinin anti-malaria drugs as well as the regular use of bacillus Calmette-Guerin (BCG) vaccine for TB prevention. The vaccine produced an almost life-long immunity to TB and meningitis to its recipients. We are thus calling for a COVID-19 containment and clinical management protocol that will incorporate the use of the anti-malaria ACT drug cocktail and BCG vaccine on compassionate ground. Twit Text FOAVip Re-reading ACT, BCG, and Low COVID-19 in Africa ????SN Compr Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=33458569 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33458569 #FOAvip English Wikipedia <ref>{{Cite pmid|33458569}}</ref> Re-reading ACT, BCG, and Low COVID-19 in Africa #MMPMID33458569 Kangbai JB; Babawo LS; Kaitibi D; Sandi AA; George AM; Sahr F SN Compr Clin Med 2021[]; 3 (1): 11-15 PMID33458569show ga October 11, 2020, marks the seventh month since the World Health Organization (WHO) officially declared COVID-19 a pandemic. Unlike other coronavirus diseases, there is a geographically disproportionate distribution of the incidence of COVID-19 cases around the world. We observed a significantly high COVID-19 cases and deaths in countries and territories with no or very small number of malaria cases or no or low national TB cases in 2018. We speculate that the high incidence of COVID-19 cases and deaths in countries less affected by malaria is partly due to overexposure to malaria which led to the regular use of the artemisinin anti-malaria drugs as well as the regular use of bacillus Calmette-Guerin (BCG) vaccine for TB prevention. The vaccine produced an almost life-long immunity to TB and meningitis to its recipients. We are thus calling for a COVID-19 containment and clinical management protocol that will incorporate the use of the anti-malaria ACT drug cocktail and BCG vaccine on compassionate ground. äRe-reading ACT, BCG, and Low COVID-19 in Africa (epmc).pdf DeepDyve Pubget Overpricing